Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2012
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172377 Pyrido[4,3-b]indoles and methods of use
07/05/2012US20120172376 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012US20120172375 Compounds and methods of promoting oligodendrocyte precursor differentiation
07/05/2012US20120172373 Method of treating cognitive impairments and schizophrenias
07/05/2012US20120172366 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
07/05/2012US20120172362 Therapeutic agent for anxiety disorders
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/05/2012US20120172354 Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines
07/05/2012US20120172353 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172350 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/05/2012US20120172348 Sterol derivative
07/05/2012US20120172347 8-oxodihydropurine derivative
07/05/2012US20120172346 Use of nicotinic acetylcholine receptor alpha 7 activators
07/05/2012US20120172339 Angiogenic resorcinol derivatives
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172335 Substituted benzimidazolone derivatives, medicaments comprising them and their use
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120172304 Intranasal carbetocin formulations and methods for the treatment of autism
07/05/2012US20120172300 Remodeling and glycopegylation of fibroblast growth factor (fgf)
07/05/2012US20120171307 Magnesium Compositions and Uses Thereof for Neurological Disorders
07/05/2012US20120171303 Compositions and methods for ehnancing cognitive and related functions in animals
07/05/2012US20120171297 Threo-dops controlled release formulation
07/05/2012US20120171296 Rapidly disintegrating solid preparation
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171282 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
07/05/2012US20120171278 Percutaneous absorption type plaster
07/05/2012US20120171277 Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist
07/05/2012US20120171275 Local administration of gallium compositions to treat pain
07/05/2012US20120171253 Fibromodulin Peptide
07/05/2012US20120171247 Novel proteins within the type e botulinum neurotoxin complex
07/05/2012US20120171239 Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171222 Methods and compositions involving nucleotide repeat disorders
07/05/2012US20120171216 Palmitated monoclonal antibody
07/05/2012US20120171215 Nogo-a binding molecules and pharmaceutical use thereof
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171178 Nutritional composition for supporting brain development and function of children
07/05/2012US20120171177 Nutritional composition for supporting brain development and function of toddlers
07/05/2012US20120171170 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
07/05/2012US20120171165 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012US20120171161 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120171125 Methods for Enhancing the Cognitive Function
07/05/2012US20120171120 Low affinity blood brain barrier receptor antibodies and uses therefor
07/05/2012US20120171118 Treatment of meningeal and neural diseases
07/05/2012US20120168335 Fast Disintegrating Compositions of Meloxicam, Processes for Preparation, and Use to Treat Arthritis and/or Pain
07/05/2012CA2845505A1 Substituted hydrogenated thieno-pyrrolo[3,2-c]pyridine, ligands, a pharmaceutical composition and a method for using the above
07/05/2012CA2823306A1 Combination of components for the prevention and treatment of frailty
07/05/2012CA2822528A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
07/05/2012CA2822500A1 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012CA2821863A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/04/2012EP2471916A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis
07/04/2012EP2471530A1 Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers
07/04/2012EP2470545A1 Anhydrate forms of a pyridine derivative
07/04/2012EP2470540A1 Novel forms of a multicyclic compound
07/04/2012EP2470525A1 Piperidine derivatives used as orexin antagonists
07/04/2012EP2470524A1 Pyrrolidine derivatives as nk3 receptor antagonists
07/04/2012EP2470523A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
07/04/2012EP2470522A1 Np-1 antagonists and their therapeutic use
07/04/2012EP2470520A1 Chromone derivatives, a process for their preparation and their therapeutic applications
07/04/2012EP2470510A1 Substituted imidazole derivatives for treatment of alzheimers disease
07/04/2012EP2470269A1 Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis
07/04/2012EP2470213A1 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
07/04/2012EP2470211A1 Antibodies that bind tau oligomers
07/04/2012EP2470181A1 Method of treating compulsive disorders with alpha-2b adrenergic receptor agonists
07/04/2012EP2470180A2 Gaba release-regulating agent in cerebellum
07/04/2012EP2470176A1 Composition and method for treating cognitive impairments in down syndrom subjects
07/04/2012EP2470168A1 Methods for the prevention and treatment of cerebral ischemia
07/04/2012EP2285784B1 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazole as 5-hydroxytryptamine-6 ligand
07/04/2012EP2229150B1 Systems and methods for delivery of materials
07/04/2012EP1874306B1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1786759B1 Novel derivatives of 3,5-seco-4-norcholestane and use thereof
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN1964703B Immediate release pharmaceutical tablets with height greater than width
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1918284B Stem cells
07/04/2012CN1874777B 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN102549007A Method for making 3alpha-hydroxy, 3beta- methyl-5alpha-pregnan-20-one (ganaxolone)
07/04/2012CN102548990A Inhibitors of phosphatidylinositol 3-kinase
07/04/2012CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
07/04/2012CN102548982A Azetidinyl diamides as monoacylglycerol lipase inhibitors
07/04/2012CN102548976A (Thio) morpholine derivatives as S1P modulators
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102548964A Etomidate analogues that do not inhibit adrenocortical steroid synthesis
07/04/2012CN102548945A Apogossypolone derivatives as anticancer agents
07/04/2012CN102548571A Compositions and methods for prevention and treatment of brain diseases and conditions
07/04/2012CN102548567A Composition comprising curcuma longa extract together with curcuma zedoaria extract
07/04/2012CN102548555A Compositions and methods for treating parkinson's disease
07/04/2012CN102548550A Exo-S-mecamylamine method, use, and compound for treatment
07/04/2012CN102533918A Method for preparing rapeseed active polypeptides
07/04/2012CN102533855A Gene-vector composition of targeted microglia as well as preparation method and application of gene-vector composition
07/04/2012CN102533755A Human miR-328 antisense nucleic acid and application thereof
07/04/2012CN102533653A 5-HT nerve cells induced by MSCs and ASCs and microencapsulation preparation method and application thereof
07/04/2012CN102533519A Method for preparing male silkworm moth spirits
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1833